JP2010504336A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504336A5
JP2010504336A5 JP2009529248A JP2009529248A JP2010504336A5 JP 2010504336 A5 JP2010504336 A5 JP 2010504336A5 JP 2009529248 A JP2009529248 A JP 2009529248A JP 2009529248 A JP2009529248 A JP 2009529248A JP 2010504336 A5 JP2010504336 A5 JP 2010504336A5
Authority
JP
Japan
Prior art keywords
gly
asp
item
pro
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009529248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/020445 external-priority patent/WO2008036387A2/en
Publication of JP2010504336A publication Critical patent/JP2010504336A/ja
Publication of JP2010504336A5 publication Critical patent/JP2010504336A5/ja
Pending legal-status Critical Current

Links

JP2009529248A 2006-09-22 2007-09-21 血管内皮機能不全を治療する方法 Pending JP2010504336A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84641806P 2006-09-22 2006-09-22
US84800406P 2006-09-28 2006-09-28
US92264607P 2007-04-10 2007-04-10
PCT/US2007/020445 WO2008036387A2 (en) 2006-09-22 2007-09-21 Method of treating endothelial dysfunction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013089123A Division JP2013166774A (ja) 2006-09-22 2013-04-22 血管内皮機能不全を治療する方法

Publications (2)

Publication Number Publication Date
JP2010504336A JP2010504336A (ja) 2010-02-12
JP2010504336A5 true JP2010504336A5 (enExample) 2010-11-11

Family

ID=39201107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009529248A Pending JP2010504336A (ja) 2006-09-22 2007-09-21 血管内皮機能不全を治療する方法
JP2013089123A Pending JP2013166774A (ja) 2006-09-22 2013-04-22 血管内皮機能不全を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013089123A Pending JP2013166774A (ja) 2006-09-22 2013-04-22 血管内皮機能不全を治療する方法

Country Status (7)

Country Link
US (2) US8334259B2 (enExample)
EP (1) EP2063910A2 (enExample)
JP (2) JP2010504336A (enExample)
CN (1) CN101563102B (enExample)
CA (1) CA2663547C (enExample)
TW (1) TWI486168B (enExample)
WO (1) WO2008036387A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124173A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for cardiac revascularization and cardiac repair
WO2009120307A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
AU2009229395A1 (en) * 2008-03-26 2009-10-01 The Board Of Regents, The University Of Texas System Method of treating degenerative diseases
WO2009120304A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
CA2802176A1 (en) * 2010-06-11 2011-12-15 The Board Of Regents, The University Of Texas System Methods of mitigating effects of radiation and reducing the risk of systemic infection
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
WO2019084540A1 (en) 2017-10-27 2019-05-02 Zeta Biolongevity, Inc. COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURY AND ENDOTHELIAL EROSION
US10905738B2 (en) * 2018-07-05 2021-02-02 Biozeus Desenvolvimento De Produtos Biofarmacêuticos Synthetic peptides, prodrugs, pharmaceutical compositions and uses
CN113092756A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液凝血酶原及其多肽片段在过敏性疾病中的应用
US20230165943A1 (en) * 2020-04-07 2023-06-01 Darrell Carney Tp508 acute therapy for patients with respiratory virus infection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5244460A (en) 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
AU6778794A (en) 1993-04-29 1994-11-21 Washington University Use of platelet-derived growth factor to improve collateral circulation
AU719366B2 (en) 1995-10-24 2000-05-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Novel peptide
US5912229A (en) 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US6197751B1 (en) 1997-11-10 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Thymosin α1 promotes tissue repair, angiogenesis and cell migration
US6033436A (en) 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
MXPA00010110A (es) 1998-04-17 2002-08-06 Angiogenix Inc Factores angiogenicos terapeuticos y metodos para su uso.
WO2000024412A2 (en) 1998-10-26 2000-05-04 Ludwig Institute For Cancer Research Use of vegf-c or vegf-d gene or protein to prevent restenosis
US6363938B2 (en) 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
TWI257307B (en) * 2000-07-12 2006-07-01 Orthologic Corp Pharmaceutical composition for cardiac tissue repair
AU2001273561B2 (en) * 2000-07-20 2004-10-28 Orthologic Corp. Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
DE60239705D1 (de) * 2002-01-16 2011-05-19 Capstone Therapeutics Corp Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur
EP1539214A4 (en) 2002-07-02 2008-01-02 Orthologic Corp Thrombin
JP4668612B2 (ja) * 2002-07-02 2011-04-13 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体ダイマー
CA2551525C (en) * 2003-12-31 2013-02-19 David W. Hobson Pharmaceutical composition for thrombin peptide derivatives

Similar Documents

Publication Publication Date Title
JP2010504336A5 (enExample)
ES2610356T3 (es) Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
JP6272907B2 (ja) 代謝障害の処置における組成物及び使用方法
RU2558301C2 (ru) Полипептиды для связывания с "рецептором конечных продуктов гликирования", а также их композиции и способы, в которых они принимают участие
JP2025143268A (ja) 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤
JP2014508510A5 (enExample)
KR20110020903A (ko) 키메라 나트륨이뇨성 폴리펩티드 및 심장 리모델링 억제 방법
JP2014512343A (ja) 多価ヘテロマルチマー足場設計及び構築物
JP2012511314A5 (enExample)
CA2931309A1 (en) Compositions and methods for treating pulmonary hypertension
JP2019506140A5 (enExample)
JP2008500373A5 (enExample)
CN105658228B (zh) 结合人类补体c5的稳定多肽
KR20140059249A (ko) 나트륨이뇨 폴리펩티드
JP2022008474A5 (enExample)
KR20210015898A (ko) Nav1.7 모노클로날 항체
ES2685987T3 (es) Análogos de péptidos gip
JP2006507229A5 (enExample)
JP2025116068A (ja) 腎臓活性融合タンパク質及びそれを使用する治療方法
JPWO2021191447A5 (enExample)
Zhang et al. Design and biological evaluation of novel long-acting adalimumab Fab conjugated with the albumin binding domain
JPWO2021229076A5 (enExample)
CN110981967B (zh) α-芋螺毒素Mr1.1的二聚体、合成方法及应用
CA2719940A1 (en) Methods for treating acute myocardial infarction
JP2011515471A5 (enExample)